Human Papillomavirus in Non-Oropharyngeal Head and Neck Cancers: A Systematic Literature Review

被引：193
作者：
Isayeva T. [1 ]
Li Y. [2 ]
Maswahu D. [1 ,2 ]
Brandwein-Gensler M. [3 ]
机构：
[1] Department of Pathology, University of Alabama at Birmingham, Birmingham, AL
[2] Department of Preventative Medicine, University of Alabama at Birmingham, Birmingham, AL
[3] Surgical Pathology Section, Division Anatomic Pathology, NP 3545, University of Alabama at Birmingham, Birmingham, AL 35233-1932
来源：
Head and Neck Pathology | 2012年 / 6卷 / Suppl 1期
关键词：
HPV; Laryngeal; Larynx; Mucoepidermoid carcinoma; Oral cavity; Salivary; Squamous carcinoma;
D O I：
10.1007/s12105-012-0368-1
中图分类号：
学科分类号：
摘要：
Perhaps one of the most important developments in head and neck oncology of the past decade is the demonstration that patients with human papillomavirus (HPV)-mediated oropharyngeal cancers have significantly improved outcomes, compared to HPV-negative counterpart patients. This has become the basis for clinical trials investigating the impact on "treatment deintensification" for patients with HPV-mediated oropharyngeal cancers. Unfortunately, the significance of HPV in non-oropharyngeal head and neck cancers is much less certain. Our goal is to systematically review the published data regarding the role HPV in carcinomas of the oral cavity, larynx, sinonasal tract and nasopharynx with respect to HPV detection frequency, viral activity, and association with outcome. We also present preliminary data on HPV16/18 transcriptional status in oral cavity carcinomas, as well as salivary gland neoplasia, as determined by nested reverse transcription PCR for HPV E6/E7 RNA. The weighted prevalence (WP) of HPV DNA detection in 4,195 oral cavity cancer patients is 20.2 %, (95 % CI 16.0 %, 25.2 %). HPV16 is the most common type detected. Importantly, no data currently demonstrates a significant association between the presence of HPV DNA and improved outcome. The WP of HPV DNA in 1,712 laryngeal cancer patients is 23.6 %, (95 % CI 18.7 %, 29.3 %). Similarly, no association has yet been demonstrated between HPV DNA status and outcome. The WP of HPV DNA detection in 120 sinonasal cancer patients is 29.6 % (95 % CI 17.8 %, 44.9 %), and in 154 nasopharyngeal carcinoma patients is 31.1 %, (95 % CI 20.3 %, 44.5 %). Recent preliminary data also suggests an association between HPV and certain salivary gland neoplasms. The clinical significance of these findings is unclear. The published data strongly support the need for studies on patients with oral and laryngeal carcinomas that will be powered to find any differences in clinical outcome with respect to HR-HPV and p16 overexpression. © 2012 Springer Science+Business Media, LLC.
引用
收藏
页码：104 / 120
页数：16
相关论文
共 122 条
[1]  
Manjarrez M.E., Ocadiz R., Valle L., Et al., Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors, Clin Cancer Res., 12, pp. 6946-6951, (2006)
[2]  
Venuti A., Badaracco G., Rizzo C., Et al., Presence of HPV in head and neck tumours: high prevalence in tonsillar localization, J Exp Clin Cancer Res., 23, pp. 561-566, (2004)
[3]  
Badaracco G., Rizzo C., Mafera B., Et al., Molecular analyses and prognostic relevance of HPV in head and neck tumours, Oncol Rep., 17, pp. 931-939, (2007)
[4]  
Szarka K., Tar I., Feher E., Et al., Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential, Oral Microbiol Immunol., 24, pp. 314-318, (2009)
[5]  
Feher E., Gall T., Murvai M., Et al., Investigation of the occurrence of torque tenovirus in malignant and potentially malignant disorders associated with human papillomavirus, J Med Virol., 81, pp. 1975-1981, (2009)
[6]  
van Houten V.M., Snijders P.J., van den Brekel M.W., Et al., Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas, Int J Cancer., 93, pp. 232-235, (2001)
[7]  
Braakhuis B.J., Snijders P.J., Keune W.J., Et al., Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus, J Natl Cancer Inst., 96, pp. 998-1006, (2004)
[8]  
Morshed K., Polz-Dacewicz M., Szymanski M., Polz D., Short-fragment PCR assay for highly sensitive broad-spectrum detection of human papillomaviruses in laryngeal squamous cell carcinoma and normal mucosa: clinico-pathological evaluation, Eur Arch Otorhinolaryngol., 265, (2008)
[9]  
Morshed K., Association between human papillomavirus infection and laryngeal squamous cell carcinoma, J Med Virol., 82, pp. 1017-1023, (2010)
[10]  
Smith E.M., Summersgill K.F., Allen J., Et al., Human papillomavirus and risk of laryngeal cancer, Ann Otol Rhinol Laryngol., 109, pp. 1069-1076, (2000)
12345678910